65 related articles for article (PubMed ID: 12102601)
1. The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: shoot the messenger.
Berg RW; Ferguso PJ; DeMoor JM; Vincen MD; Koropatnick J
Curr Drug Targets; 2002 Aug; 3(4):297-309. PubMed ID: 12102601
[TBL] [Abstract][Full Text] [Related]
2. Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cells.
Ferguson PJ; DeMoor JM; Vincent MD; Koropatnick J
Br J Pharmacol; 2001 Dec; 134(7):1437-46. PubMed ID: 11724749
[TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex.
Chu E; Copur SM; Ju J; Chen TM; Khleif S; Voeller DM; Mizunuma N; Patel M; Maley GF; Maley F; Allegra CJ
Mol Cell Biol; 1999 Feb; 19(2):1582-94. PubMed ID: 9891091
[TBL] [Abstract][Full Text] [Related]
4. Targeting a regulatory element in human thymidylate synthase mRNA.
Brunn ND; Garcia Sega E; Kao MB; Hermann T
Chembiochem; 2012 Dec; 13(18):2738-44. PubMed ID: 23143777
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Human Uracil DNA Glycosylase Sensitizes a Large Fraction of Colorectal Cancer Cells to 5-Fluorodeoxyuridine and Raltitrexed but Not Fluorouracil.
Christenson ES; Gizzi A; Cui J; Egleston M; Seamon KJ; DePasquale M; Orris B; Park BH; Stivers JT
Mol Pharmacol; 2021 Jun; 99(6):412-425. PubMed ID: 33795350
[TBL] [Abstract][Full Text] [Related]
6. In vitro selection of an RNA sequence that interacts with high affinity with thymidylate synthase.
Lin X; Mizunuma N; Chen T; Copur SM; Maley GF; Liu J; Maley F; Chu E
Nucleic Acids Res; 2000 Nov; 28(21):4266-74. PubMed ID: 11058126
[TBL] [Abstract][Full Text] [Related]
7. Role of cysteine amino acid residues on the RNA binding activity of human thymidylate synthase.
Lin X; Liu J; Maley F; Chu E
Nucleic Acids Res; 2003 Aug; 31(16):4882-7. PubMed ID: 12907731
[TBL] [Abstract][Full Text] [Related]
8. Structure of an RNA dimer of a regulatory element from human thymidylate synthase mRNA.
Dibrov S; McLean J; Hermann T
Acta Crystallogr D Biol Crystallogr; 2011 Feb; 67(Pt 2):97-104. PubMed ID: 21245530
[TBL] [Abstract][Full Text] [Related]
9. An insight into thymidylate synthase inhibitor as anticancer agents: an explicative review.
Sen A; Karati D
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; ():. PubMed ID: 38446215
[TBL] [Abstract][Full Text] [Related]
10. Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy.
Haritha NH; Nawab A; Vijayakurup V; Anto NP; Liju VB; Alex VV; Amrutha AN; Aiswarya SU; Swetha M; Vinod BS; Sundaram S; Guijarro MV; Herlevich T; Krishna A; Nestory NK; Bava SV; Sadasivan C; Zajac-Kaye M; Anto RJ
Front Oncol; 2021; 11():656804. PubMed ID: 34336653
[TBL] [Abstract][Full Text] [Related]
11. Targeting CCR3 with antagonist SB 328437 sensitizes 5‑fluorouracil‑resistant gastric cancer cells: Experimental evidence and computational insights.
Gutiérrez Á; Reyes ME; Larronde C; Brebi P; Mora-Lagos B
Oncol Lett; 2024 Jul; 28(1):296. PubMed ID: 38737977
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Alpha-Tocopheryl Succinate as a Cancer Treatment Agent Led to the Development of Methods to Potentially Improve the Efficacy of Cancer Therapy.
Prasad KN
J Am Nutr Assoc; 2023; 42(8):776-782. PubMed ID: 36735863
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterisation of a nucleotide based pro-drug formulated with a peptide into a nano-chemotherapy for colorectal cancer.
Wilson JJ; Bennie L; Eguaogie O; Elkashif A; Conlon PF; Jena L; McErlean E; Buckley N; Englert K; Dunne NJ; Tucker JHR; Vyle JS; McCarthy HO
J Control Release; 2024 Mar; 369():63-74. PubMed ID: 38513729
[TBL] [Abstract][Full Text] [Related]
14. New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids.
Patutina OA; Mironova NL; Vlassov VV; Zenkova MA
Acta Naturae; 2009 Jul; 1(2):44-60. PubMed ID: 22649602
[TBL] [Abstract][Full Text] [Related]
15. Turning up the heat on essential E. coli genes.
Kumar A; Stirling PC
Mol Syst Biol; 2023 Oct; 19(10):e11933. PubMed ID: 37718698
[TBL] [Abstract][Full Text] [Related]
16. mRNA Epi-Drugs: The Possible Use and Potential of mRNA in Radiation Therapy.
Cattaneo CG; De Felice F
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1344-1346. PubMed ID: 37943219
[No Abstract] [Full Text] [Related]
17. Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined "Complementary Lethality".
Rytelewski M; Ferguson PJ; Maleki Vareki S; Figueredo R; Vincent M; Koropatnick J
Mol Ther Nucleic Acids; 2013 Mar; 2(3):e78. PubMed ID: 23481354
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation and cell cycle block are the keys for 5-fluorouracil induced up-regulation of human thymidylate synthase expression.
Ligabue A; Marverti G; Liebl U; Myllykallio H
PLoS One; 2012; 7(10):e47318. PubMed ID: 23056627
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic studies of semicarbazone triapine targeting human ribonucleotide reductase in vitro and in mammalian cells: tyrosyl radical quenching not involving reactive oxygen species.
Aye Y; Long MJC; Stubbe J
J Biol Chem; 2012 Oct; 287(42):35768-35778. PubMed ID: 22915594
[TBL] [Abstract][Full Text] [Related]
20. Antisense targeting of thymidylate synthase (TS) mRNA increases TS gene transcription and TS protein: effects on human tumor cell sensitivity to TS enzyme-inhibiting drugs.
Jason TL; Berg RW; Vincent MD; Koropatnick J
Gene Expr; 2007; 13(4-5):227-39. PubMed ID: 17605297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]